Video on Unlocking the Strategic Value of Freedom to Operate

For any organization invested in research and development, IP landscaping and Freedom to Operate (FTO) analysis can serve as a vital roadmap as you bring your product to life – and finally to market.

In this video, LifeSciences BC and members of Gowling WLG’s Life Sciences Group along with Ben Thiede of Stemcell Technologies, explore strategies for managing IP risks and opportunities in an innovative life sciences enterprise.